ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Britain’s Cancer Czar Begins Examination of Risks and Benefits of Mammography

October 28, 2011

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988

2018 State of Cancer Care in America

February 3, 2022

Michael Atkins Named Deputy Director at Georgetown Lombardi Cancer Center

March 2, 2012

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994

Advisors Call for External Oversight, Coordination of NCI Clinical Trials.

February 25, 2005